Skip Navigation LinksHome   >   Research & Development   >   Cannabinoid Derivative Library

Cannabinoid Derivative Library

OCT has developed an extensive library of proprietary cannabinoid derivative compounds. These are produced on a continual basis using the latest medicinal chemistry techniques, resulting in an “evergreen” library of cannabinoid derivatives. 

Derivatives are designed to harness the therapeutic potential of phytocannabinoids, and the low toxicity shown by many natural compounds, while improving properties such as efficacy and bioavailability. As part of its R&D activities, OCT has produced cannabinoid derivatives based not only on the major cannabinoids, but also rare cannabinoids. 

Emphasis is put on the unique structure of the compounds and ensuring that they are diverse from existing derivatives. This ensures their patentability and increases the potential for isolating treatments for new diseases.